ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,190, issued on Sept. 8, was assigned to Baylor College of Medicine (Houston).
"Coronavirus main protease inhibitors and methods using same" was invented by Srinivas Chamakuri (Houston), Shuo Lu (Houston), Melek Nihan Ucisik (Medford, Mass.), Ying-Chu Chen (Acton, Mass.), John C. Faver (Medford, Mass.), Ravikumar Jimmidi (Houston), Martin M. Matzuk (Houston), Timothy Palzkill (Houston), Zhifeng Yu (Wayland, Mass.) and Damian W. Young (Houston).
According to the abstract* released by the U.S. Patent & Trademark Office: "In one aspect, the present disclosure provides compounds which inhibit a coronavirus main protease. In another aspect, the present disclosure provides a method of t...